Grant List
Represents Grant table in the DB
GET /v1/grants?page%5Bnumber%5D=1384&sort=-program_officials
{ "links": { "first": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1&sort=-program_officials", "last": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1405&sort=-program_officials", "next": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1385&sort=-program_officials", "prev": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1383&sort=-program_officials" }, "data": [ { "type": "Grant", "id": "9492", "attributes": { "award_id": "75N93019C00051-P00008-9999-2", "title": "CIVICS PROGRAM - SARS-CoV-2 STUDIES", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-10", "end_date": "2025-08-04", "award_amount": 457311, "principal_investigator": { "id": 25201, "first_name": "FLORIAN", "last_name": "KRAMMER", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 625, "ror": "https://ror.org/04a9tmd77", "name": "Icahn School of Medicine at Mount Sinai", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 625, "ror": "https://ror.org/04a9tmd77", "name": "Icahn School of Medicine at Mount Sinai", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true }, "abstract": "This contract supports the design and evaluation of innovative vaccine candidates and delivery platforms that aim to achieve durable, robust and broadly protective immunity. Activities may include immunologic analyses to inform vaccine design and identify surrogates/correlates of protection; in vitro and in vivo immunogenicity and efficacy testing; assay and reagent development; and clinical studies and trials. Additional studies are being conducted to evaluate the immune response to SARS-CoV-2 infection.", "keywords": [ "2019-nCoV", "Biological Assay", "COVID-19", "Clinical Research", "Clinical Trials", "Development", "Evaluation", "Immune response", "Immunity", "Immunologics", "In Vitro", "Reagent", "SARS-CoV-2 infection", "Support Contracts", "Therapeutic Human Experimentation", "Vaccine Design", "design", "efficacy testing", "immunogenicity", "in vivo", "innovation", "programs", "vaccine candidate", "vaccine delivery" ], "approved": true } }, { "type": "Grant", "id": "9493", "attributes": { "award_id": "6U48DP006381-03M001", "title": "UMass Worcester Prevention Research Center - COVID 19 Supplement", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-30", "end_date": "2024-09-29", "award_amount": 310000, "principal_investigator": { "id": 25202, "first_name": "Stephenie C.", "last_name": "Lemon", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 790, "ror": "", "name": "UNIV OF MASSACHUSETTS MED SCH WORCESTER", "address": "", "city": "", "state": "MA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [ { "id": 25203, "first_name": "MILAGROS C", "last_name": "ROSAL", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 790, "ror": "", "name": "UNIV OF MASSACHUSETTS MED SCH WORCESTER", "address": "", "city": "", "state": "MA", "zip": "", "country": "United States", "approved": true }, "abstract": null, "keywords": [], "approved": true } }, { "type": "Grant", "id": "9494", "attributes": { "award_id": "75N93019C00044-P00006-9999-2", "title": "Adjuvant testing pipeline for recombinant SARS-CoV2 vaccines", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-30", "end_date": "2024-09-29", "award_amount": 257000, "principal_investigator": { "id": 11930, "first_name": "OFER", "last_name": "LEVY", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 798, "ror": "https://ror.org/00dvg7y05", "name": "Boston Children's Hospital", "address": "", "city": "", "state": "MA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 798, "ror": "https://ror.org/00dvg7y05", "name": "Boston Children's Hospital", "address": "", "city": "", "state": "MA", "zip": "", "country": "United States", "approved": true }, "abstract": "To identify the optimal adjuvant for recombinant SARS-CoV2 vaccines for vaccine recipients of different ages, and to identify correlates of protection against SARS-CoV2 infection or disease, experimental SARS-CoV2 vaccines will be formulated with a panel of different vaccine adjuvants and tested side-by-side for immunogenicity and efficacy.", "keywords": [ "2019-nCoV", "Adjuvant", "Age", "Age-Months", "Antibodies", "Antigens", "Biological Assay", "COVID-19 vaccine", "Cells", "Contractor", "Contracts", "Disease", "Double-Stranded RNA", "Enzyme-Linked Immunosorbent Assay", "Flow Cytometry", "Government", "Immune", "Immunization", "Immunoglobulin G", "In Vitro", "Injections", "Modeling", "Mus", "Poly I-C", "Proteins", "Reaction", "Recombinants", "SARS-CoV-2 infection", "Side", "Site", "Source", "Structure of germinal center of lymph node", "T-Cell Activation", "T-Lymphocyte", "Testing", "Vaccine Adjuvant", "Vaccines", "draining lymph node", "immunogenicity", "in vivo", "lymphoid organ", "novel", "polarized cell", "programs", "transcriptomics", "vaccine candidate", "vaccine evaluation" ], "approved": true } }, { "type": "Grant", "id": "9495", "attributes": { "award_id": "75N93019C00044-P00002-9999-2", "title": "Adjuvant testing pipeline for recombinant SARS-CoV2 vaccines", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-30", "end_date": "2024-09-29", "award_amount": 1790282, "principal_investigator": { "id": 11930, "first_name": "OFER", "last_name": "LEVY", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 798, "ror": "https://ror.org/00dvg7y05", "name": "Boston Children's Hospital", "address": "", "city": "", "state": "MA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 798, "ror": "https://ror.org/00dvg7y05", "name": "Boston Children's Hospital", "address": "", "city": "", "state": "MA", "zip": "", "country": "United States", "approved": true }, "abstract": "To identify the optimal adjuvant for recombinant SARS-CoV2 vaccines for vaccine recipients of different ages, and to identify correlates of protection against SARS-CoV2 infection or disease, experimental SARS-CoV2 vaccines will be formulated with a panel of different vaccine adjuvants and tested side-by-side for immunogenicity and efficacy.", "keywords": [ "2019-nCoV", "Adjuvant", "Age", "Age-Months", "Antibodies", "Antigens", "Biological Assay", "Cells", "Contractor", "Contracts", "Disease", "Double-Stranded RNA", "Enzyme-Linked Immunosorbent Assay", "Flow Cytometry", "Government", "Immune", "Immunization", "Immunoglobulin G", "In Vitro", "Infection", "Injections", "Modeling", "Mus", "Poly I-C", "Proteins", "Reaction", "Recombinants", "Side", "Site", "Source", "Structure of germinal center of lymph node", "T-Cell Activation", "T-Lymphocyte", "Testing", "Vaccine Adjuvant", "Vaccines", "draining lymph node", "immunogenicity", "in vivo", "lymphoid organ", "novel", "polarized cell", "programs", "transcriptomics", "vaccine candidate", "vaccine evaluation" ], "approved": true } }, { "type": "Grant", "id": "9498", "attributes": { "award_id": "6U48DP006384-02M001", "title": "Connecting Behavioral Science to COVID-19 Vaccine Demand (CBS-CVD) Network", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-30", "end_date": "2024-09-29", "award_amount": 500000, "principal_investigator": { "id": 12477, "first_name": "Tamar", "last_name": "Mendelson", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 344, "ror": "https://ror.org/00za53h95", "name": "Johns Hopkins University", "address": "", "city": "", "state": "MD", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 344, "ror": "https://ror.org/00za53h95", "name": "Johns Hopkins University", "address": "", "city": "", "state": "MD", "zip": "", "country": "United States", "approved": true }, "abstract": null, "keywords": [], "approved": true } }, { "type": "Grant", "id": "9499", "attributes": { "award_id": "75N93019C00050-P00005-9999-3", "title": "CIVIC SARS-CoV-2 Research Activities", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-10", "end_date": "2022-07-31", "award_amount": 1141458, "principal_investigator": { "id": 25208, "first_name": "TONY", "last_name": "MOODY", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 246, "ror": "https://ror.org/00py81415", "name": "Duke University", "address": "", "city": "", "state": "NC", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 246, "ror": "https://ror.org/00py81415", "name": "Duke University", "address": "", "city": "", "state": "NC", "zip": "", "country": "United States", "approved": true }, "abstract": "To support the design and evaluation of innovative candidate products and delivery platforms that aim to achieve durable, robust and broadly protective immunity against viruses.", "keywords": [ "2019-nCoV", "COVID-19", "COVID-19 vaccine", "Evaluation", "Immunity", "Research Activity", "Virus", "design", "innovation", "vaccine development" ], "approved": true } }, { "type": "Grant", "id": "9500", "attributes": { "award_id": "75N93019C00050-P00005-9999-1", "title": "CIVIC SARS-CoV-2 Research Activities", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-10", "end_date": "2022-07-31", "award_amount": 515384, "principal_investigator": { "id": 25208, "first_name": "TONY", "last_name": "MOODY", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 246, "ror": "https://ror.org/00py81415", "name": "Duke University", "address": "", "city": "", "state": "NC", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 246, "ror": "https://ror.org/00py81415", "name": "Duke University", "address": "", "city": "", "state": "NC", "zip": "", "country": "United States", "approved": true }, "abstract": "To support the design and evaluation of innovative candidate products and delivery platforms that aim to achieve durable, robust and broadly protective immunity against viruses.", "keywords": [ "2019-nCoV", "COVID-19 therapeutics", "Coronavirus", "Evaluation", "Immunity", "Research Activity", "Virus", "design", "innovation", "therapeutic development" ], "approved": true } }, { "type": "Grant", "id": "9506", "attributes": { "award_id": "75N93019C00058-P00002-9999-2", "title": "Advanced Development of Medical Countermeasures for Infectious Diseases - COVID-19 Related Studies", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-09", "end_date": "2020-12-31", "award_amount": 51953, "principal_investigator": { "id": 25213, "first_name": "GEORGE", "last_name": "PAINTER", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 265, "ror": "https://ror.org/03czfpz43", "name": "Emory University", "address": "", "city": "", "state": "GA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 265, "ror": "https://ror.org/03czfpz43", "name": "Emory University", "address": "", "city": "", "state": "GA", "zip": "", "country": "United States", "approved": true }, "abstract": "To support the advanced development of a promising candidate therapeutic. The research and development activities to be supported will allow the candidate therapeutic product to progress along the product development pathway, and include preclinical and IND enabling development activities, and clinical safety and efficacy assessment.", "keywords": [ "2019-nCoV", "Advanced Development", "COVID-19", "Clinical", "Communicable Diseases", "Development", "Influenza Therapeutic", "Pathway interactions", "Safety", "medical countermeasure", "pre-clinical", "product development", "research and development", "therapeutic candidate" ], "approved": true } }, { "type": "Grant", "id": "9507", "attributes": { "award_id": "6U48DP006380-02M001", "title": "Connecting Behavioral Science to COVID-19 Vaccine Demand (CBS-CVD) Network", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-30", "end_date": "2024-09-29", "award_amount": 499989, "principal_investigator": { "id": 25214, "first_name": "Rafael", "last_name": "Perez-Escamilla", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 452, "ror": "https://ror.org/03v76x132", "name": "Yale University", "address": "", "city": "", "state": "CT", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 452, "ror": "https://ror.org/03v76x132", "name": "Yale University", "address": "", "city": "", "state": "CT", "zip": "", "country": "United States", "approved": true }, "abstract": null, "keywords": [], "approved": true } }, { "type": "Grant", "id": "9508", "attributes": { "award_id": "6U48DP006392-02M002", "title": "DP19-001, Policy, Practice and Prevention Research Center (P3RC) at the University of Illinois at Chicago (UIC) COVID-19 Supplement", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [], "start_date": "2019-09-30", "end_date": "2024-09-29", "award_amount": 500000, "principal_investigator": { "id": 25215, "first_name": "Lisa", "last_name": "Powell", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 163, "ror": "https://ror.org/02mpq6x41", "name": "University of Illinois at Chicago", "address": "", "city": "", "state": "IL", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 163, "ror": "https://ror.org/02mpq6x41", "name": "University of Illinois at Chicago", "address": "", "city": "", "state": "IL", "zip": "", "country": "United States", "approved": true }, "abstract": null, "keywords": [], "approved": true } } ], "meta": { "pagination": { "page": 1384, "pages": 1405, "count": 14046 } } }